Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal
Vincerx Pharma (OTC Pink: VINC) announced the adjournment of its Special Meeting of Stockholders to August 27, 2025, seeking approval for the company's liquidation and dissolution proposal. The company has revised its potential distribution estimate to $0.03 to $0.07 per share of common stock, subject to timely approval of the dissolution.
The board unanimously recommends stockholders vote FOR the proposal, emphasizing that delays will result in continued operating costs and could further reduce or eliminate potential distributions. U.S. stockholders may be eligible for capital loss tax benefits if they receive less than their tax basis in shares. The company has provided multiple voting options, including phone and internet methods, through their proxy solicitor Advantage Proxy.
Vincerx Pharma (OTC Pink: VINC) ha annunciato il rinvio della sua Assemblea Straordinaria degli Azionisti al 27 agosto 2025, per ottenere l'approvazione della proposta di liquidazione e scioglimento della società. L'azienda ha aggiornato la stima della possibile distribuzione a da 0,03 a 0,07 dollari per azione di azioni ordinarie, subordinata all'approvazione tempestiva dello scioglimento.
Il consiglio di amministrazione raccomanda all'unanimità agli azionisti di votare a FAVORE della proposta, sottolineando che ritardi comporterebbero costi operativi continui e potrebbero ridurre ulteriormente o annullare le potenziali distribuzioni. Gli azionisti statunitensi potrebbero beneficiare di vantaggi fiscali per perdite in conto capitale se ricevono un importo inferiore al costo fiscale delle azioni. La società ha fornito diverse modalità di voto, inclusi telefono e internet, tramite il loro incaricato per il voto per delega Advantage Proxy.
Vincerx Pharma (OTC Pink: VINC) anunció el aplazamiento de su Junta Especial de Accionistas hasta el 27 de agosto de 2025, buscando la aprobación de la propuesta de liquidación y disolución de la compañía. La empresa ha revisado su estimación de distribución potencial a entre $0.03 y $0.07 por acción de acciones ordinarias, sujeta a la aprobación oportuna de la disolución.
La junta recomienda por unanimidad a los accionistas votar A FAVOR de la propuesta, enfatizando que los retrasos implicarían costos operativos continuos y podrían reducir o eliminar aún más las distribuciones potenciales. Los accionistas estadounidenses podrían ser elegibles para beneficios fiscales por pérdidas de capital si reciben menos que su base fiscal en acciones. La empresa ha proporcionado múltiples opciones de votación, incluyendo métodos telefónicos e internet, a través de su gestor de votos por poder Advantage Proxy.
Vincerx Pharma (OTC Pink: VINC)는 회사의 청산 및 해산 제안 승인을 위해 주주 특별총회를 2025년 8월 27일로 연기한다고 발표했습니다. 회사는 해산이 적시에 승인될 경우 보통주 한 주당 0.03달러에서 0.07달러의 잠재적 배당 추정치를 수정했습니다.
이사회는 만장일치로 주주들에게 제안에 찬성표를 던질 것을 권고하며, 지연 시 계속되는 운영 비용과 잠재적 배당금의 추가 감소 또는 소멸이 발생할 수 있음을 강조했습니다. 미국 주주들은 주식의 세금 기준액보다 적은 금액을 받을 경우 자본 손실 세금 혜택을 받을 수 있습니다. 회사는 Advantage Proxy라는 위임장 대리인을 통해 전화 및 인터넷 등 다양한 투표 방법을 제공하고 있습니다.
Vincerx Pharma (OTC Pink : VINC) a annoncé le report de son Assemblée Générale Extraordinaire des actionnaires au 27 août 2025, afin d’obtenir l’approbation de la proposition de liquidation et dissolution de la société. La société a révisé son estimation de distribution potentielle à entre 0,03 $ et 0,07 $ par action d’actions ordinaires, sous réserve d’une approbation en temps voulu de la dissolution.
Le conseil d’administration recommande à l’unanimité aux actionnaires de voter POUR la proposition, soulignant que tout retard entraînerait des coûts opérationnels continus et pourrait réduire davantage ou annuler les distributions potentielles. Les actionnaires américains pourraient être éligibles à des avantages fiscaux en cas de pertes en capital s’ils reçoivent un montant inférieur à leur base fiscale des actions. La société a mis à disposition plusieurs options de vote, y compris par téléphone et internet, via leur mandataire Advantage Proxy.
Vincerx Pharma (OTC Pink: VINC) gab die Verschiebung seiner außerordentlichen Hauptversammlung auf den 27. August 2025 bekannt, um die Zustimmung zum Vorschlag der Liquidation und Auflösung des Unternehmens einzuholen. Das Unternehmen hat seine geschätzte potenzielle Ausschüttung auf 0,03 bis 0,07 USD pro Stammaktie angepasst, vorbehaltlich einer rechtzeitigen Genehmigung der Auflösung.
Der Vorstand empfiehlt den Aktionären einstimmig, FÜR den Vorschlag zu stimmen, und betont, dass Verzögerungen zu fortlaufenden Betriebskosten führen und potenzielle Ausschüttungen weiter reduzieren oder ganz eliminieren könnten. US-Aktionäre könnten steuerliche Vorteile bei Kapitalverlusten erhalten, wenn sie weniger als ihre steuerliche Basis für die Aktien erhalten. Das Unternehmen bietet mehrere Abstimmungsoptionen, einschließlich Telefon- und Internetmethoden, über seinen Stimmrechtsvertreter Advantage Proxy an.
- Potential distribution of $0.03 to $0.07 per share to stockholders upon dissolution approval
- Possible tax benefits for U.S. stockholders through capital loss recognition
- Multiple convenient voting methods provided for stockholders
- Continued delays in dissolution approval causing ongoing operating costs
- Risk of reduced or eliminated stockholder distributions due to delays
- Potential need to seek bankruptcy court protection as alternative
- Significant decline in potential shareholder value
Insights
Vincerx urges shareholder approval for dissolution, offering $0.03-0.07/share potential distribution; delays will further deplete remaining assets.
Vincerx Pharma's announcement reveals a company in its final stages, seeking shareholder approval for dissolution with a revised distribution estimate of only
The repeated adjournment of the special meeting (now postponed until August 27) indicates difficulty achieving the required shareholder vote threshold, despite the board's unanimous recommendation. This creates a troubling scenario where continued delays directly erode the already minimal potential shareholder recovery.
The company's urgent tone underscores a critical financial situation - each day without approval means ongoing operational expenses that further diminish the already minimal asset pool. With trading on the OTC Pink market (a significant downgrade from prior NASDAQ listing), Vincerx is operating on extremely limited resources.
The mention of potential tax benefits through capital loss recognition provides a secondary but important consideration for shareholders facing significant investment losses. However, this will be little consolation given the dramatic loss in share value.
Most concerning is the company's explicit warning that continued delays might necessitate bankruptcy protection as an alternative to the proposed dissolution. This indicates management's assessment that assets are rapidly depleting, making this vote genuinely time-sensitive for preserving any remaining shareholder value.
Revised Potential Distribution Range of
based on current estimates and assumptions
Failure to approve Dissolution Proposal on a timely basis will result in continued operating
costs and further reduce or eliminate any potential distributions to stockholders
SAN MATEO, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today, has again been adjourned, this time until 10:00 a.m., Pacific time, on August 27, 2025 via live audio webcast at www.virtualshareholdermeeting.com/VINC2025SM2. This additional adjournment will allow Vincerx more time to solicit the votes needed to approve the Dissolution Proposal
Vincerx currently estimates a revised range of between
Vincerx is urging ALL stockholders to vote IMMEDIATELY FOR the Dissolution Proposal.
Vincerx’s board of directors unanimously recommends that stockholders vote FOR the Dissolution Proposal and believes that approval of the Dissolution Proposal is extremely important to stockholders for a number of reasons, including the following:
- Preserve Possibility of Distributions. Vincerx currently estimates a revised range of between
$0.03 t o$0.07 per share of its outstanding common stock that could potentially be available for distribution. However, additional delays in approving the Dissolution Proposal will result in continued operating costs and expenses – further reducing or eliminating funds available for distribution to stockholders. Approving the Dissolution Proposal will allow Vincerx to move forward expeditiously and maximize the likelihood and amount of distributions to stockholders. - Recognize Potential Tax Benefits. U.S. stockholders who receive less than their tax basis in their shares could be eligible to recognize a capital loss for U.S. federal income tax purposes. Timely approval of the Dissolution Proposal will facilitate this recognition.
Every vote matters. Stockholders must ACTIVELY VOTE for their vote to count. Further delay in approving the Dissolution Proposal will result in continued expenditures and reduce the likelihood and amounts available for distribution to stockholders.
Voting is quick and simple:
- BY PHONE: Please call Advantage Proxy, Vincerx’s proxy solicitor, toll-free at 1-877-870-8565 between the hours of 9:00 a.m. and 9:00 p.m., Eastern Time, Monday through Friday. You can also contact Advantage Proxy if you have any questions about voting.
- BY INTERNET: Vote by going to www.proxyvote.com and entering the control number on your proxy card or by following the instructions provided by your broker, bank, or other nominee.
Your vote FOR the Dissolution Proposal is very important - please VOTE TODAY.
Additional Information
Information regarding the Dissolution Proposal, including the board of director’s reasons for recommending approval of the Dissolution Proposal, is set forth in the company’s proxy statement and supplements thereto, which have been filed with the Securities and Exchange Commission (“SEC”) and are available at the SEC’s website at www.sec.gov.
Forward-Looking Information
This press release contains forward-looking statements within the meaning of the federal securities laws including, but not limited to, statements about the reasons for approving, and the consequences of failing to approve, the Dissolution Proposal; the amounts potentially available for distribution to stockholders; and the potential tax benefits to stockholders of approving the Dissolution Proposal. Forward-looking statements involve risks and uncertainties that may cause actual results or performance to differ materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, risks involved in dissolving, liquidating, and winding down Vincerx’s business and affairs; the timing and amount of distributions, if any, to Vincerx’s stockholders, and the accuracy of, and changes to, the assumptions used in estimating such amounts; Vincerx’s operating costs and expenses, including any unexpected costs, expenses, or claims; the ability to obtain stockholder approval of the Dissolution Proposal and the timeliness of such approval; the risk that Vincerx may need to seek alternatives to the Dissolution, including seeking protection of the bankruptcy court; and the other factors discussed in Vincerx’s SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and subsequent reports filed with the SEC. All forward-looking statements are based on information available to Vincerx as of the date of this press release. Vincerx undertakes no duty or obligation to update these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Contact Information:
info@vincerx.com
FAQ
What is the current estimated distribution range for VINC stockholders?
When is the rescheduled Special Meeting for VINC stockholders?
What happens if VINC stockholders don't approve the Dissolution Proposal?
What are the tax implications for VINC stockholders if the dissolution is approved?
How can VINC stockholders vote on the Dissolution Proposal?
